Recent research demonstrates that cannabidiphorol (CBDP) acts as a negative allosteric modulator at CB1 receptors through a novel dual-site mechanism. This finding suggests CBDP could potentially provide therapeutic cannabinoid system modulation without psychoactive effects, though clinical applications remain theoretical. The study represents important mechanistic research that expands our understanding of cannabinoid receptor pharmacology.
The “entourage effect” isn’t bro science, minor cannabinoids and terpenes physically bind to …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Entourage EffectCannabinoid ReceptorsProduct SelectionDosingPharmacology Why This Matters This research provides molecular evidence for cannabinoid...
Regulatory Digest 2026-03-07
✦ New Regulatory updates (digest-only, lower relevance) (57) [regulations.gov] Importer of Controlled-Bright Green(2024-20083)DEA1426 (57) [regulations.gov] Importer of Controlled-Cambridge Isotope(2024-20082)DEA1429 (57) [regulations.gov] Importer of Controlled-Biopharmaceutical(2024-20085)DEA1425 (57) [regulations.gov] Importer Controlled-VA Cooperative (2024-11795) DEA1374 (57)...
Cannabinoid Clinical Trials: GLP-1 Receptors and Mental Health
Clinical Takeaway GLP-1 receptor agonists showed measurable effects on risk for several common mental health conditions in this Mendelian randomization analysis, suggesting these medications may influence psychiatric outcomes beyond their metabolic effects....
Endocannabinoid System: Cannabis & Maternal Cytokines
Clinical Takeaway Cannabis use during pregnancy is linked to measurable suppression of key immune signaling proteins (cytokines) in the mother’s bloodstream. Because these cytokines play a critical role in supporting a healthy...
Endocannabinoid System & GLP-1 Receptor Mental Health Evidence
Clinical Takeaway GLP-1 receptor agonists, the drug class that includes medications like semaglutide, were studied for their potential causal effects on ten common mental health conditions using genetic analysis data. The findings...
Endocannabinoid System & GLP-1 Mental Health Evidence
Clinical Takeaway GLP-1 receptor agonists, the drug class that includes medications like semaglutide, were studied using genetic analysis to assess their causal effect on ten psychiatric conditions. The findings suggest these medications...